Type 2 Diabetes
Reduction in intramuscular LCFA-CoAs is linked to high insulin sensitivity
Published in Obesity and Diabetes Week, January 9th, 2006
In a recently published article, scientists in the United States conducted a study "to investigate the effect of a sustained (7-day) decrease in plasma free fatty acid (FFA) concentrations on insulin action and intramyocellular long-chain fatty acyl-CoAs (LCFA-CoAs), we studied the effect of acipimox, a potent inhibitor of lipolysis, in seven type 2 diabetic patients (age 53±3 years, BMI 30.2±2.0 kg/m2, fasting plasma glucose...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
High visceral fat mass amount is linked to metabolic changes in offspring of diabetics - Diet & Nutrition
Low calorie diet prevents diabetic nephropathy in the obese - Obesity Complications
Increasing BMI is strongly related to the CHD risk factors systolic blood pressure and HDL - Obesity Pathogenesis
When lipid levels are high, isoflavones fail to lower plasma triglyceride - Pediatric Diabetes
Impaired glucose tolerance and type 2 diabetes mellitus are common in obese youth - ACE Inhibitors
Angiotensin-converting enzyme inhibitors may be linked to weight maintenance in elderly - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
